We are live on ! Find out more
SHPH icon

Shuttle Pharmaceuticals

5 hedge funds and large institutions have $169K invested in Shuttle Pharmaceuticals in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

56% less capital inflows, than outflows

Capital inflows: $148K | Capital outflows: $337K

64.12% less ownership

Funds ownership: 65% → 0.88% (-64%)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SHPH Hedge Fund Activity: Q3 2026 in Review

5 of the 8,114 institutional investors tracked by Wall St. Rank reported a position in Shuttle Pharmaceuticals (SHPH) for Q3 2026, worth a combined $169K — down 50% from $338K a quarter earlier.

Fund positioning in SHPH was balanced in Q3 2026: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $69.8K. The largest seller was HRT Financial, exiting entirely with an estimated $255K sold.

  • 5 institutional investors held Shuttle Pharmaceuticals (SHPH) as of Q3 2026, unchanged from Q2 2026.
  • Funds reported $169K of Shuttle Pharmaceuticals stock for Q3 2026, down 50% quarter-over-quarter.
  • 3 funds opened new Shuttle Pharmaceuticals positions in Q3 2026 and 3 closed out, a net change of 0 holders.
  • The largest Shuttle Pharmaceuticals buyer in Q3 2026 was Jane Street, an estimated $69.8K added.
  • The largest Shuttle Pharmaceuticals seller in Q3 2026 was HRT Financial, an estimated $255K sold.

Based on aggregated 13F filings for Q3 2026.